Changes could reduce compounding regulatory burden

The US Government is making moves to address drug shortages—which could have consequences for Australia Food and Drug Administration (FDA) Commissioner Scott Gottlieb has said his administration is looking to bolster the number of compounding pharmacies registering to become official ‘outsourcing facilities’. These facilities would be called on to manufacture pharmaceuticals during times of commercial